1-4 of 4
Gizelle Popradi, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Less Chronic Graft-Versus-Host Disease, Immunosuppressive Therapy and Better Survival after Anti-Thymocyte Globulin in Unrelated Donor Stem Cell Transplant Recipients: Longer Follow-up of a Multicentre Cell Therapy Transplant Canada Randomized Trial

Jean Roy, MD, Tony Panzarella, M.Sc., P.Stat, Stephen Couban, MDBSc, Félix Couture, MD FRCPC, Gerald M. Devins, PhD, Mohamed Elemary, MD, Stephen Ronan Foley, MD FRCPC, Genevieve Gallagher, MD, John Kuruvilla, MD, Stephanie J. Lee, MD MPH, John Moore, MDFRACP,FRCPA, Thomas J Nevill, MD, Gizelle Popradi, MD FRCP, Kirk R. Schultz, MD, David Szwajcer, MD FRCPC, Cynthia L Toze, MD FRCPC, Irwin Walker, MBBS, FRCPC
Journal: Blood
Blood (2019) 134 (Supplement_1): 875.
https://doi.org/10.1182/blood-2019-123275
Published: 2019
Journal Articles

Impact of Myeloablative Versus Reduced Intensity Conditioning Regimens on Early Lymphocyte Recovery and Its Impact on Transplant Outcomes after Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients with Hematologic Malignancies.

Dong Hwan (Dennis) Kim, MD, PhD, Gizelle Popradi, MD, John Kuruvilla, MD, Vikas Gupta, MD, Mark Minden, MD, PhD, Jeffrey H. Lipton, MD, PhD, Hans A. Messner, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 5039.
https://doi.org/10.1182/blood.V110.11.5039.5039
Published: 2007
Journal Articles

Late Onset Eosinophilia (beyond Day 100), Rather Than Early Onset Eosinophilia, Has a Significant Prognostic Impact on Transplant Outcomes after Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT).

Dong Hwan (Dennis) Kim, MD, PhD, Gizelle Popradi, MD, John Kuruvilla, MD, Vikas Gupta, MD, Mark Minden, MD, PhD, Hans A. Messner, MD, PhD, Jeffrey H. Lipton, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1062.
https://doi.org/10.1182/blood.V110.11.1062.1062
Published: 2007
Journal Articles

Early Recovery of Absolute Lymphocyte Count (ALC) Is a Predictor of Long-Term Outcome Following Related Allogeneic Peripheral Blood Stem Cell Transplantation in Adults with AML/MDS.

Gizelle Popradi, MD, Dong Hwan (Dennis) Kim, MD/PhD, John Kuruvilla, MD, Vikas Gupta, MD, Mark Minden, MD/PhD, Jeffrey H. Lipton, MD/PhD, Hans A. Messner, MD/PhD
Journal: Blood
Blood (2007) 110 (11): 1102.
https://doi.org/10.1182/blood.V110.11.1102.1102
Published: 2007